Follow
TANUJA SASWAT
TANUJA SASWAT
Post-doctoral Research Fellow
Verified email at nih.gov
Title
Cited by
Cited by
Year
Cytokine signature associated with disease severity in dengue
ARK Patro, S Mohanty, BK Prusty, DK Singh, S Gaikwad, T Saswat, ...
Viruses 11 (1), 34, 2019
762019
High rates of co-infection of Dengue and Chikungunya virus in Odisha and Maharashtra, India during 2013
T Saswat, A Kumar, S Kumar, P Mamidi, S Muduli, NK Debata, NS Pal, ...
Infection, Genetics and Evolution 35, 134-141, 2015
752015
Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea (MBZM-N-IBT)
P Mishra, A Kumar, P Mamidi, S Kumar, I Basantray, T Saswat, I Das, ...
Scientific reports 6 (1), 20122, 2016
712016
Molecular epidemiology of Japanese encephalitis virus in pig population of Odisha, Assam and Manipur states of India
A Datey, LM Singh, U Rajkhowa, BK Prusty, T Saswat, P Mamidi, ...
Infection, Genetics and Evolution 83, 104325, 2020
112020
Epidemiological trends and molecular dynamics of dengue, chikungunya virus infection, coinfection, and other undifferentiated fever during 2015‐2016 in Odisha, India
T Saswat, N Sahoo, S Muduli, NK Debata, S Chattopadhyay, ...
Journal of Medical Virology 91 (2), 163-170, 2019
102019
Inhibition of chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea (MBZM-N-IBT). Sci Rep 6: 20122
P Mishra, A Kumar, P Mamidi, S Kumar, I Basantray, T Saswat, I Das, ...
102016
Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies
A Kumar, S De, AK Moharana, TK Nayak, T Saswat, A Datey, P Mamidi, ...
Virology Journal 18 (1), 103, 2021
82021
Cytokine signature associated with disease severity in dengue. Viruses. 2019; 11 (1): 34
A Patro, S Mohanty, BK Prusty, DK Singh, S Gaikwad, T Saswat, ...
4
Molecular characterisation of the genomic Variation in dengue and chikungunya viruses
T Saswat
Bhubaneshwar, 0
The system can't perform the operation now. Try again later.
Articles 1–9